Arthex Biotech SL

Arthex Biotech SL is an SME in Valencia, Spain that has taken part in 3 EU-funded projects since 2023, receiving €2.5M in EU funding and leading 1 as coordinator.

EU funding received€2.5M
EU projects3
As coordinator1
Running now2
First EU project2023
Latest project2025
CountrySpain
EU registration (PIC)892852118
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Arthex Biotech SL's own share of each project, not the project's full budget.

  • Horizon Europe€2.5M · 3 projects

Projects

3 EU-funded projects, newest first. Arthex Biotech SL led 1 of them as coordinator. Each links to the official record.

  • ENTRY-DMAssociated partner

    Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

  • RETORNAAssociated partner

    Targeting RNA as an approach for treating retinal disease

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

  • fight-dm1Coordinator

    First In class oliGo THerapy for Myotonic Dystrophy type 1 (DM1)

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €2.5Mtheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • entrepreneurship
  • ophthalmology

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime